The Effects of Dapagliflozin in Normal Clinical Practice in T2D

Clinical trial NCT05418946 · UNKNOWN

Trial details

NCT number: NCT05418946
Sponsor: University of Milan
Status: UNKNOWN
Study type: OBSERVATIONAL

Type 2 Diabetes

Start date: 2022-06-01
Primary completion: 2022-12-01
Enrollment: 1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.